Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEROfen: Nebulized Fentanyl in Healthy Volunteers
NCT06281951Phase 1Recruiting
- Sponsor
- Rouen University Hospital
- Start
- Apr 2024
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of fentanyl citrate nasal spray in pain (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Measurement of fentanyl bioavailability via facial nebulization and intranasal inhalation at 6 hours. Started Apr 2024; status: recruiting.
02
Drugs
fentanyl citrate nasal spray
03
Conditions
pain
Beyond the preview
Go deeper on NCT06281951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06281951.